Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride.
Greenwald
M
M
Wadsworth VA Medical Center, Los Angeles, CA.
Brandli
D
D
Spector
S
S
Silverman
S
S
Golde
G
G
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000368:Aged; D015519:Bone Density / Q000187:drug effects*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced*; D011241:Prednisone / Q000009:adverse effects; D011446:Prospective Studies; D012969:Sodium Fluoride / Q000494:pharmacology / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D003692:Delayed-Action Preparations; D012969:Sodium Fluoride; D011241:Prednisone